Bowel Incontinence Clinical Trials

Find Bowel Incontinence Clinical Trials Near You

Adherence Assessment in Transanal Irrigation : Validation of the Transanal Irrigation Adherence Scale

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Transanal irrigation (TAI) is a method used to empty stools from the recto-sigmoid and colon (from the descending colon to the transverse colon). It is recommended for treating evacuation disorders (bowel movements) or continence issues (fecal incontinence). It is a second-line treatment, offered after the failure of hygienic-dietary rules, perineal physiotherapy, and conventional drug treatments (suppositories, obturator plugs, etc.), in combination with treatments for transit constipation (hygienic-dietary rules and laxatives) if necessary. The effectiveness of TAI has been widely demonstrated, particularly in neurological populations (spinal cord injuries, spina bifida, multiple sclerosis, etc.), but also in non-neurological populations, with a significant reduction in symptoms (constipation or incontinence) and an improvement in quality of life compared to medical treatment Despite demonstrated effectiveness with a long-term success rate of 50% among users, only 42% of patients continue use 21 months after learning the technique. The aim of this study is to validate a tool for assessing patient adherence to the TAI device in order to identify non-adherent patients and subsequently determine the reasons for non-adherence to optimize treatment, in the absence of non-surgical therapeutic alternatives The primary objective of this study is the psychometric validation of a transanal irrigation adherence self-questionnaire scale (TRIAL) in French. The secondary objectives are assessing : 1/ correlation between the final score of TRIAL with sides effects reported, the using modalities, indications of this treatment, and patient's satisfaction. 2/ quality of life of these patients using the Transanal irrigation device. 3/ correlation between the final score of TRIAL and stool diary in order to define the cut-offs of strong, moderate and low adherence of this scale.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients using ICT for at least 1 month

• Patients with anorectal disorders of neurological or neurological or non-neurological origin

• Patients whose indication for TCI is constipation, anorectal and/or fecal incontinence.

• Adult patients

• Informed patients who do not object to participating in the study.

Locations
Other Locations
France
Service de Neuro-urologie et explorations périnéales Hôpital Pitié Salpêtrière
RECRUITING
Paris
Contact Information
Primary
Maëlys TENG, MD, MSc
maelys.teng@aphp.fr
0033 1 42 16 36 74
Backup
Gerard AMARENCO, MD, PhD
gerard.amarenco@aphp.fr
0033 1 42 16 36 75
Time Frame
Start Date: 2026-03-30
Estimated Completion Date: 2028-09-30
Participants
Target number of participants: 100
Sponsors
Leads: Assistance Publique - Hôpitaux de Paris

This content was sourced from clinicaltrials.gov